Superficial Basal Cell Carcinoma — Trials

Superficial Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 40%
Top sponsor: Biofrontera Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00604890	Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma	completed	Phase 1 / Phase 2	186	BPGbioINDUSTRY	1	Feb 28, 2025	clinicaltrials
NCT04470726	Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype(NMSC)	completed	Phase 1 / Phase 2	26	AiViva BioPharma, Inc.INDUSTRY	1	Dec 27, 2024